BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  ProMetic Life Sci Receives Clearance From Health Canada To Proceed With Its PBI-4050 Placebo-Controlled Phase 2 Clinical Trial In Patients With Metabolic Syndrome And Type 2 Diabetes

  November 16, 2016

   · 

  6 min read
• Drug Development

  Regeneron And Sanofi Present Results From Phase 3 MONARCH Study Of Investigational Sarilumab At American College of Rheumatology Annual Meeting

  November 16, 2016

   · 

  12 min read
• Drug Development

  CytoDyn’s Two-Year Update On Its PRO 140 Monotherapy Study In HIV Accepted At CROI 2017

  November 16, 2016

   · 

  7 min read
• Medicines360 And Allergan Announce Study Publication Evaluating Pelvic Infection Risk Following Same-Day Sexually Transmitted Infection Testing And Liletta (Levonorgestrel-Releasing Intrauterine System) 52 Mg Placement

  November 16, 2016

   · 

  12 min read
• Business

  Nabriva Reports Third Quarter 2016 Financial Results

  November 16, 2016

   · 

  1 min read
• Drug Development

  Heat Biologics To Present Topline HS-410 Phase II Bladder Cancer Results At The Society Of Urological Oncology Annual Meeting

  November 16, 2016

   · 

  3 min read
• Drug Development

  Aclaris Announces Positive Top-Line Phase III Results For A-101 In Treating Seborrheic Keratosis, A Common Undertreated Skin Condition

  November 16, 2016

   · 

  9 min read
• Drug Development

  Boehringer Ingelheim Release: Updated Phase III Results Reinforce Safety And Efficacy Of Praxbind (Idarucizumab) In Urgent Situations

  November 16, 2016

   · 

  12 min read
• Pharm Country

  Nature’s Research Journal Scientific Reports Proves Noom Coach Is Effective In Driving Sustained Weight Loss Across Large Populations

  November 16, 2016

   · 

  4 min read
• Business

  PharmaMar Appoints Pascal Besman As Chief Operating Officer Of PharmaMar U.S.

  November 16, 2016

   · 

  1 min read